Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...
When cases of plague pop up in the US, it can feel straight up medieval. It's treatable, but how and why does it persist?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback